Scholar Rock Holding (SRRK) Invested Capital (2017 - 2026)
Scholar Rock Holding (SRRK) posted quarterly Invested Capital of $1.6 million for Q2 2024, down 71.13% quarter-over-quarter from $5.5 million in Q1 2024.
Powered by 
Analysis
Scholar Rock Holding (SRRK) Invested Capital (2017 - 2026) Analysis & Trends
Scholar Rock Holding's Invested Capital history runs 7 years deep, the most recent figure standing at $1.6 million for Q2 2024.
- In Q2 2024, Invested Capital changed N/A year-over-year to $1.6 million; the TTM figure through Mar 2025 stood at $1.6 million (down 76.77% YoY), while the FY2023 annual figure was $1.3 million, changed N/A from the prior year.
- Invested Capital for Q2 2024 stood at $1.6 million, down from $5.5 million in the prior quarter.
- The five-year high for Invested Capital was $11.6 million in Q2 2022, with the low at $805000.0 in Q3 2022.
- The 4-year median for Invested Capital is $1.6 million (2024), against an average of $4.1 million.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | 33.70 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | 7.35 Bn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 6.25 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | 19.13 Bn |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 1.30 Bn |
| 10 | Scholar Rock Holding | 7.25 Bn | 7.25 Bn | - | 449.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 449.99 Mn |
| Mar 31, 2026 | 472.63 Mn |
| Dec 31, 2025 | 345.20 Mn |
| Sep 30, 2025 | 344.61 Mn |
| Jun 30, 2025 | 283.05 Mn |
| Mar 31, 2025 | 362.07 Mn |
| Dec 31, 2024 | 418.78 Mn |
| Sep 30, 2024 | 129.30 Mn |
| Jun 30, 2024 | 351.66 Mn |
| Mar 31, 2024 | 238.37 Mn |
| Dec 31, 2023 | 276.57 Mn |
| Sep 30, 2023 | 217.62 Mn |
| Jun 30, 2023 | 252.40 Mn |
| Mar 31, 2023 | 278.48 Mn |
| Dec 31, 2022 | 309.98 Mn |
| Sep 30, 2022 | 344.64 Mn |
| Jun 30, 2022 | 391.47 Mn |
| Mar 31, 2022 | 228.09 Mn |
| Dec 31, 2021 | 223.65 Mn |
| Sep 30, 2021 | 212.19 Mn |